Medical device maker Intuitive beats estimates on strong demand for surgical robots
Reuters
Published Apr 18, 2024 04:52PM ET
(Reuters) - Intuitive Surgical (NASDAQ:ISRG) beat Wall Street estimates for first-quarter profit and revenue on Thursday, riding on higher demand for its robots used in minimally invasive procedures.
Investor expectations around the performance of medical device makers have been heightened since last November, as people, especially older adults, opted for medical procedures deferred during the pandemic.
Intuitive, which makes surgical robots called da Vinci, earned $1.50 per share on an adjusted basis for the quarter ended March 31. Analysts on average estimated $1.41, according to LSEG data.
The company's sales rose 11% to $1.89 billion for the quarter, compared with the estimated $1.87 billion.
Worldwide, da Vinci procedures grew about 16% compared with the first quarter of 2023.
Shares of the California-based company were up more than 3% in trading after the bell.
Industry bellwether and rival Johnson & Johnson (NYSE:JNJ) said on Tuesday it continues to expect medtech-related procedure volumes to remain elevated through 2024, despite missing estimates for its quarterly medical sales.
Brokerage Evercore ISI had then said a decline in sales for J&J's surgical devices likely reflects loss of market share to Intuitive.
Intuitive had forecast in January procedures using its da Vinci surgical robot to grow between 13% and 16% in 2024. That compares with an about 22% growth in 2023.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.